Skip to main content
OpenTrials

Clinical trial condition

Myosarcoma

Explore clinical trials studying Myosarcoma. Study availability and eligibility vary by location and protocol.

198 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Myosarcoma trial results

Completed

Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

NCT00354835

Conditions
Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma, Childhood Botryoid-Type Embryonal Rhabdomyosarcoma, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 226 locations
View Trial Details
Completed

Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma

NCT00876031

Conditions
Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +7 more
Locations
  • Krankenhaus der Stadt Dornbirn Dornbirn, Austria
  • Universitätsklinik für Kinder- und Jugendheilkunde Graz, Austria
  • Universitätsklinik für Kinder- und Jugendheilkunde Innsbruck, Austria
  • Landeskrankenhaus Klagenfurt, Austria
View all 87 locations
View Trial Details
Completed

Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS)

NCT03441360

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors

NCT03245450

Conditions
Ewing Sarcoma, Myosarcoma, Neoplasms, +11 more
Locations
  • Hopitaux de La Timone Marseille, Bouches-du-Rhône, France
  • Centre Oscar Lambret Lille, Nord, France
  • Centre Léon Berard Lyon, Rhône, France
  • Eisai Trial Site 4 Freiburg im Breisgau, Baden-Wurttemberg, Germany
View all 39 locations
View Trial Details
Completed

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

NCT02982941

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Desmoplastic Small Round Cell Tumor, Ewing Sarcoma, +33 more
Locations
  • Lucile Packard Children's Hospital, Stanford Palo Alto, California, United States
  • National Cancer Institute, Center for Cancer Research Bethesda, Maryland, United States
  • Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • Texas Children's Hospital Houston, Texas, United States
View Trial Details
Completed

Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

NCT02452554

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +45 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
View all 69 locations
View Trial Details
Completed

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

NCT00075582

Conditions
Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 163 locations
View Trial Details

Related conditions